BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 2869404)

  • 1. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
    Giros B; Gros C; Solhonne B; Schwartz JC
    Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.
    Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B
    Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor.
    Chaillet P; Marçais-Collado H; Costentin J; Yi CC; De La Baume S; Schwartz JC
    Eur J Pharmacol; 1983 Jan; 86(3-4):329-36. PubMed ID: 6572590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enkephalin degradation in the guinea-pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatin.
    Cohen ML; Geary LE; Wiley KS
    J Pharmacol Exp Ther; 1983 Feb; 224(2):379-85. PubMed ID: 6822962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hydrolysis of [leu]enkephalin and D-ala2-[L-leu]enkephalin in rat plasma.
    Weinberger SB; Martinez JL
    J Pharmacol Exp Ther; 1988 Oct; 247(1):129-35. PubMed ID: 2902210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Some features of enkephalin metabolism in the rat brain after administration of bestatin].
    Beliaev NA; Kolesanova EF; Baronets VIu; Panchenko LF
    Biokhimiia; 1993 Jul; 58(7):1033-46. PubMed ID: 8364122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolysis of [Leu]enkephalin by chick plasma in vitro.
    Shibanoki S; Weinberger SB; Beniston D; Nudelman KA; Schulteis G; Bennett EL; Rosenzweig MR; Ishikawa K; Martinez JL
    J Pharmacol Exp Ther; 1991 Feb; 256(2):650-5. PubMed ID: 1994000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of low-molecular-weight opioid peptides by vascular plasma membrane aminopeptidase M.
    Bausback HH; Ward PE
    Biochim Biophys Acta; 1986 Jul; 882(3):437-44. PubMed ID: 2873842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of enkephalin degradation in rat plasma.
    Weinberger SB; Zafuto CE; Walker RC; Martinez JL
    NIDA Res Monogr; 1986; 75():263-6. PubMed ID: 3123942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of the evoked liberation of (Met5)enkephalin from slices of globus pallidus in the presence of thiorphan and bestatin].
    Giros B; de la Baume S; Gros C; Schwartz JC
    C R Seances Acad Sci III; 1983; 297(13):609-12. PubMed ID: 6424884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of the aminopeptidase inhibitor bestatin on the enkephalin level in the rat brain].
    Beliaev NA; Kolesanova EF; Kelesheva LF; Rotanova TV; Panchenko LF
    Biull Eksp Biol Med; 1990 Nov; 110(11):474-5. PubMed ID: 2083325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of aminopeptidases from Aplysia californica.
    Bawab W; Querido E; Crine P; DesGroseillers L
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):967-75. PubMed ID: 1417757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
    Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
    J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of enkephalin by brain enzymes.
    Vogel Z; Altstein M
    Prog Biochem Pharmacol; 1980; 16():49-59. PubMed ID: 7003599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
    Hachisu M; Hiranuma T; Shibazaki Y; Uotani K; Murata S; Aoyagi T; Umezawa H
    Eur J Pharmacol; 1987 May; 137(1):59-65. PubMed ID: 2886348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
    Altstein M; Blumberg S; Vogel Z
    Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal absorption of peptide drug: quantitative evaluation of the degradation and the permeation of metkephamid in rat small intestine.
    Taki Y; Sakane T; Nadai T; Sezaki H; Amidon GL; Langguth P; Yamashita S
    J Pharmacol Exp Ther; 1995 Jul; 274(1):373-7. PubMed ID: 7616421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bestatin and thiorphan on [Met5]enkephalin-Arg6-Phe7-induced analgesia.
    Reggiani A; Carenzi A; Frigeni V; Della Bella D
    Eur J Pharmacol; 1984 Oct; 105(3-4):361-4. PubMed ID: 6391939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major localization of aminopeptidase M in rat brain microvessels.
    Solhonne B; Gros C; Pollard H; Schwartz JC
    Neuroscience; 1987 Jul; 22(1):225-32. PubMed ID: 2888044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endogenous tripeptide Tyr-Gly-Gly as a possible metabolite of opioid peptides in rat brain: identification, regional distribution, effects of lesions and formation in depolarized slices.
    Giros B; Llorens-Cortes C; Gros C; Schwartz JC
    Peptides; 1986; 7(4):669-77. PubMed ID: 3532054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.